Results 211 to 220 of about 32,983 (314)
MORPHOLOGICAL AND BIOCHEMICAL CORRELATES OF CEREBRAL MICROSOMES [PDF]
F. de Balbian Verster+2 more
openalex +1 more source
Abstract Omaveloxolone is approved in the United States and the European Union for the treatment of patients with Friedreich ataxia aged ≥16 years. It is mainly metabolized by cytochrome P450 (CYP) 3A4 in vitro. Two drug–drug interaction studies (NCT04008186 and NCT05909644) were performed to evaluate (1) the effect of drug‐metabolizing enzymes (DMEs ...
Hamim Zahir+4 more
wiley +1 more source
Changes in the chemical composition and the enzymic activities of hepatic microsomes of the chick embryo during development [PDF]
JK Pollak, DB Ward
openalex +1 more source
A novel system to determine activity of individual uridine 5'-diphospho-glucuronosyltransferase (UGT) isoforms: Recombinant UGT-beads. [PDF]
Wang T, Taub ME, Chan TS.
europepmc +1 more source
ABSTRACT We investigated the influence of CYP2B6, GSTP1, and SLCO1B1 star allele‐predicted phenotypes and CBR1 variants on clinical outcomes in patients with HCC receiving DOX via TACE. A prospective cohort of patients with HCC underwent DOX therapy via TACE.
Sireen Abdul Rahim Shilbayeh+5 more
wiley +1 more source
Inhibitors of Protein Synthesis in Rat Liver Microsome Fractions
Oscar A. Scornik+3 more
openalex +1 more source
Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility. [PDF]
Romero A+19 more
europepmc +1 more source
ABSTRACT Sirolimus is a third‐generation immunosuppressant with multiple efficacies, including antifungal, antitumor, and immunosuppressive properties. We conducted a pharmacokinetic study to determine the effect of berberine hydrochloride (BBR) on the pharmacokinetics of sirolimus in rats.
Yuanxia Yang+3 more
wiley +1 more source